Anebulo Pharmaceuticals, Inc. (ANEB)
OTCMKTS · Delayed Price · Currency is USD
0.2600
-0.0200 (-7.14%)
At close: Nov 20, 2026
Anebulo Pharmaceuticals Market Cap
Anebulo Pharmaceuticals has a market cap or net worth of $10.6 million as of November 20, 2026. It is the 40,728th most valuable company in the world and the 5,450th biggest in the United States. Its market cap has decreased by 88.78% in one year.
Market Cap
10.60M
Enterprise Value
1.56M
Revenue
n/a
Global Rank
Country Rank
#5,450 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since May 7, 2021, Anebulo Pharmaceuticals's market cap has decreased from 165.19M to 10.60M, a decrease of -93.58%. That is a compound annual growth rate of -39.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 10.60M | -74.45% |
| Dec 31, 2025 | 41.50M | -4.76% |
| Dec 31, 2024 | 43.57M | -29.77% |
| Dec 29, 2023 | 62.03M | -0.15% |
| Dec 30, 2022 | 62.13M | -56.73% |
| Dec 29, 2021 | 143.57M | -13.09% |
| May 7, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NDT Pharmaceuticals | 17.49M |
| Provectus Biopharmaceuticals | 17.23M |
| Biomind Labs | 16.70M |
| Vicapsys Life Sciences | 16.19M |
| Inhibitor Therapeutics | 13.90M |
| Synlogic | 11.84M |
| Brainstorm Cell Therapeutics | 10.83M |
| Hepion Pharmaceuticals | 9.92M |